Characterization of foot-and-mouth disease virus from outbreaks in Ecuador during 2009-2010 and cross-protection studies with the vaccine strain in use in the region

Vaccine

Volumn 29, Issue 46, 2011, Pages 8230-8240

  Maradei, Eduardo ^a   Perez Beascoechea, Claudia ^a   Malirat, Viviana ^b   Salgado, Gustavo ^c   Seki, Cristina ^b   Pedemonte, Andrea ^a   Bonastre, Paula ^a   D'Aloia, Ricardo ^a   La Torre, José L ^b   Mattion, Nora ^b   Rodríguez Toledo, Jorge ^a   Bergmann, Ingrid E ^b  

^a Servicio Nacional de Sanidad y Calidad Agroalimentaria Argentina   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^c Instituto de Medicina e Higiene Tropical Izquieta Perez   (Ecuador)

Author keywords

Foot and mouth disease virus; Molecular epidemiology; Monoclonal antibody profiling; Vaccine matching

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE; PROTEIN VP1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CATTLE; COMPLEMENT FIXATION TEST; CONTROLLED STUDY; CROSS PROTECTION; DRUG EFFICACY; DRUG POTENCY; ECUADOR; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PRIORITY JOURNAL; TREATMENT OUTCOME; VACCINATION; VACCINE PRODUCTION; VIRUS CHARACTERIZATION; VIRUS ISOLATION; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CAPSID PROTEINS; CATTLE; CATTLE DISEASES; CLUSTER ANALYSIS; CROSS PROTECTION; DISEASE OUTBREAKS; ECUADOR; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GENOTYPE; MOLECULAR SEQUENCE DATA; PHYLOGENY; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; SEROTYPING; VIRAL VACCINES;

EID: 80054004792     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.08.120     Document Type: Article

References (49)

1. Bachrach H.L. Foot-and-mouth disease. Annu Rev Microbiol 1968, 22:201-244.
2. Pereira H.G. Foot-and-mouth disease. Virus diseases of food animals 1981, vol. 2:333-363. Academic Press Inc., New York.
3. Holland J.J., Spindler K., Horodyski F., Grabau E., Nichol S., VandePol S. Rapid evolution of RNA genomes. Science 1982, 215:1577-1585.
4. Holland J.J., De La Torre J.C., Steinhauer D.A. RNA virus populations as quasispecies. Curr Top Microbiol Immunol 1992, 176:1-20.
5. Domingo E., Mateu M.G., Martínez M.A., Dopazo J., Moya A., Sobrino F. Genetic variability and antigenic diversity of foot-and-mouth disease virus. Applied virology research: virus variability, epidemiology and control 1990, vol. 2:233-266. Plenum Press, New York.
6. Arrowsmith A.E.M. A survey of foot-and-mouth disease type O strains from the far east. Dev Biol Stand 1977, 35:221-230.
7. Brooksby J.B. Portraits of viruses: foot-and-mouth disease virus. Intervirology 1982, 18:1-23.
8. Cartwright B., Chapman W.G., Sharpe R.T. Stimulation of heterotypic antigens of foot-and-mouth disease virus antibodies in vaccinated cattle. Res Vet Sci 1982, 32:338-342.
9. Mattion N., König G., Seki C., Smitsaart E., Maradei E., Robiolo B., et al. Reintroduction of foot-and-mouth disease in Argentina: characterization of the isolates and development of tools for the control and eradication of the disease. Vaccine 2004, 22:4149-4162.
10. Astudillo V., Rosenberg F.J., Zottele A., Casas Olascoaga R. Considerações sobre a saúde animal na América Latina. Hora Veterinária 1990, 9(54):37-43.
11. Perry B.D., Kalpravidh W., Coleman P.G., Horst H.S., McDermott J.J., Randolph T.F., et al. The economic impact of foot and mouth disease and its control in South-East Asia: a preliminary assessment with special reference to Thailand. A review. Rev Sci Tech Off Int Epiz 1999, 18(2):478-497.
12. Huang C.C., Jong M.H., Lin S.Y. Characteristics of foot and mouth disease virus in Taiwan. J Vet Med Sci 2000, 62(7):677-679.
13. Correa Melo E., Saraiva V., Astudillo V. Review of the status of foot and mouth disease in countries of South America and approaches to control and eradication. Rev Sci Tech Off Int Epiz 2002, 21(3):429-436.
14. Garland A.J. Vital elements for the successful control of foot-and-mouth disease by vaccination. Vaccine 1999, 17:1760-1766.
15. Bergmann I.E., Malirat V., Falczuk A.J. Evolving perception on the benefits of vaccination as foot-and-mouth disease control policy: contributions of South America. Expert Rev Vaccines 2005, 4(6):903-913.
16. Bahnemann H.G. Binary ethylenimine as an inactivant for foot and mouth disease and its application for vaccine production. Arch Virol 1975, 47(1):47-56.
17. Augé de Melo P., Astudillo V., Gomes I., Campos Garcia J.T. Immune response of adult cattle vaccinated with oil-adjuvanted foot-and-mouth disease vaccines. Bol Cent Panam Fiebre Aftosa 1977, 26:27-29.
18. Augé de Melo P. The use of oil-adjuvanted foot-and-mouth disease vaccine in endemic areas. Bol Cent Panam Fiebre Aftosa 1982, 45:33-42.
19. Costa Giomi M.P., Durini L., Bergmann I.E., Mazzuca G., Aued de Rau M.E., Fernández G., et al. Combined antigenic and biochemical study of prototype and field strains of FMDV in Argentina. Bul de l'Office International des Epizooties 1982, 263-270.
20. Alonso F.A., Casas Olascoaga R.C., Astudillo V.M., Sondahl M.S., Gomes I., Vianna Filho Y.L. Updating of foot-and-mouth disease virus strains of epidemiological importance in South America. Bol Cent Panam Fiebre Aftosa 1987, 53:11-18.
21. Bergmann I.E., Tiraboschi B., Mazzuca G., Fernandez E., Michailoff C.A., Scodeller E.A., et al. Serological and biochemical analysis of foot-and-mouth disease virus (serotype C3) isolated in Argentina between 1981 and 1986. Vaccine 1988, 6:245-251.
22. Malirat V., Bergmann I.E., Alonso A., Pereira P., Boller M.A. Serological and molecular characterization of foot-and-mouth disease serotype O viruses isolated from outbreaks in Brazil and Argentina between 1958 and 1983. Bol Cent Panam Fiebre Aftosa 1993, 59:147-152.
23. Malirat V., Augé de Mello P., Tiraboschi B., Beck E., Gomes I., Bergmann I.E. Genetic variation of foot-and-mouth disease virus during persistent infection in cattle. Virus Res 1994, 34:31-48.
24. Araujo J.P., Montassier H.J., Pinto A.A. Extensive antigenic and genetic variation among foot-and-mouth disease type A viruses isolated from the 1994 and 1995 foci in Sao Paulo. Brazil Vet Microbiol 2002, 84:15-27.
25. König G.A., Palma E., Maradei E., Piccone M.E. Molecular epidemiology of foot-and-mouth diseases virus types A and O isolated in Argentina during the 2000-2002 epizootic. Vet Microbiol 2007, 124:1-15.
26. Malirat V., Franca de Barros J.J., Bergmann I.E., Mendonca Campos R., Neitzert E., Veiga da Costa E., et al. Phylogenetic analysis of foot-and-mouth disease vírus type O re-remerging in free areas of South America. Virus Res 2007, 124:22-28.
27. Malirat V, Bergmann IE, Mendonca Campos R, Salgado G, Sanchez Martínez C, Conde F, et al. Phylogenetic analysis of foot-and-mouth disease virus type O circulating in the Andean region of South America during 2002-2008. Vet Microbiol, doi:10.1016/j.vetmic.2011.04.021.
28. Alonso A. Manual de Diagnostico de Laboratorio de las Enfermadedas Vesiculares, Panaftosa; 1986.
29. Alonso A., Martins M.A., Gomes D.M.P., Allende R., Sondahl M.S. Foot-and-mouth disease virus typing by complement fixation and enzyme-linked immunosorbent assay using monovalent and polyvalent antisera. J Vet Diagn Invest 1992, 4:249-253.
30. Seki C., Robiolo B., Periolo O., Iglesias M., D'Antuono A., Maradei E., et al. Rapid methodology for antigenic profiling of FMDV field strains and for the control of identity, purity and viral integrity in commercial virus vaccines using monoclonal antibodies. Vet Microbiol 2009, 133:239-251.
31. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. Mega5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol, doi:10.1093/molbev/msr121.
32. Posada D., Crandall K.A. Selecting the best-fit-model of nucleotide substitution. Syst Biol 2001, 50:580-601.
33. Rweyemamu M.M., Pay T.W.F., Parker M.J. Serological differentiation of foot-and-mouth disease virus strains in relation to selection of suitable vaccine viruses. Dev Biol Stand 1977, 35:205-214.
34. World Organisation for Animal Health Foot and mouth disease. OIE Standards Commission. Manual of diagnostic tests and vaccines for terrestrial animals 2008, Office International des Epizooties, Paris, France, chapter 2.1.5. 6th ed.
35. Rweyemamu M.M. Antigenic variation in foot-and-mouth disease: studies based on the virus neutralization reaction. J Biol Stand 1984, 12(3):323-337.
36. PANAFTOSA (Pan-American Foot-and-Mouth Disease Center). Final recommendations of the Seminario Internacional de Control de Vacuna Antiaftosa, Panaftosa, Rio de Janeiro, Brazil, 10-14 September 2001.
37. Mattion N., Smitsaart E., Mazza M., Harrison N., Filippi J., Robiolo B., et al. Emergency vaccine for foot-and-mouth disease: early immunity induction in susceptible species. Vet Argentina 1998, 148:563-572.
38. Maradei E., La Torre J., Robiolo B., Esteves J., Seki C., Pedemonte A., et al. Updating of the correlation between IpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphthovirus vaccines in Argentina. Vaccine 2008, 26:6577-6586.
39. Goris N., Maradei E., D Aloia R.D., Fondevila N., Mattion N., Perez A., et al. Foot-and-mouth disease vaccine potency testing in cattle using homologous and heterologous challenge strains: precision of the " Protection against Podal Generalisation" test. Vaccine 2008, 26:3432-3437.
40. Animal Health Service (SENASA). Act no. 351/2006. In: Boletín Oficial No. 30.940, Argentina, 5th July 2006. Available from http://infoleg.mecon.gov.ar/infolegInternet/anexos/115000-119999/117636/norma.htm.
41. Mattion N., Goris N., Willems T., Robiolo B., Maradei E., Perez Beascoechea C., et al. Some guidelines for determining foot-and-mouth disease vaccine strain matching by serology. Vaccine 2009, 27:741-747.
42. Paton D.J., Valarcher J.F., Bergmann I.E., Matlho O.G., Zakharov V.M., Palma E.L., et al. Selection of foot-and-mouth disease vaccine strains - a review. Rev Sci Tech Off Int Epiz 2005, 24(3):981-993.
43. Samuel A.R., Knowles R.J., Kitching R.P. Serological and biochemical analysis of some recent type A foot-and-mouth disease virus isolates from the middle east. Epidemiol Infect 1988, 101:577-590.
44. Hernandez J., Martinez M.A., Rocha E., Domingo E., Mateu M.G. Generation of a subtype-specific neutralisation epitope in foot-and-mouth disease vírus of a different subtype. J Gen Virol 1992, 73:213-216.
45. Barnet P.V., Samuel A.R., Statham R.J. The suitability of the emergency foot-and-mouth disease antigens held by the International Vaccine Bank within a global context. Vaccine 2001, 19:2107-2117.
46. Crowther J.R. The use of monoclonal antibodies in the molecular typing of animal viruses. Rev Sci Tech Off Int Epiz 1993, 12:369-383.
47. Tami C., Taboga O., Berinstein A., Núñez J., Palma E., Domingo E., et al. Evidence of coevolution of antigenicity and host cell tropism of foot-and-mouth disease in vivo. J Virol 2003, 77:1219-1226.
48. Sutmoller P., Barteling S.S., Casas Olascoaga R., Sumption K.J. Control and eradication of foot-and-mouth disease: a review. Virus Res 2003, 91:101-144.
49. Robiolo B., La Torre J., Maradei E., Perez Beascoechea C., Perez A., Seki C., et al. Confidence in indirect assessment of foot-and-mouth disease vaccine potency and vaccine matching carried out by liquid phase ELISA and virus neutralization tests. Vaccine 2010, 28:6235-6241.